NO984462L - Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi - Google Patents

Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi

Info

Publication number
NO984462L
NO984462L NO984462A NO984462A NO984462L NO 984462 L NO984462 L NO 984462L NO 984462 A NO984462 A NO 984462A NO 984462 A NO984462 A NO 984462A NO 984462 L NO984462 L NO 984462L
Authority
NO
Norway
Prior art keywords
spray
gene therapy
dried microparticles
therapeutic carriers
carriers
Prior art date
Application number
NO984462A
Other languages
English (en)
Norwegian (no)
Other versions
NO984462D0 (no
Inventor
Andrew Derek Utton
Jill Elizabeth Gden
Richard Alan Ohnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO984462D0 publication Critical patent/NO984462D0/no
Publication of NO984462L publication Critical patent/NO984462L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO984462A 1996-04-03 1998-09-25 Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi NO984462L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07
PCT/GB1997/000953 WO1997036578A1 (en) 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Publications (2)

Publication Number Publication Date
NO984462D0 NO984462D0 (no) 1998-09-25
NO984462L true NO984462L (no) 1998-09-25

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984462A NO984462L (no) 1996-04-03 1998-09-25 Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi

Country Status (14)

Country Link
EP (1) EP0936902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000507568A (cg-RX-API-DMAC7.html)
AR (1) AR007493A1 (cg-RX-API-DMAC7.html)
AT (1) ATE243027T1 (cg-RX-API-DMAC7.html)
AU (1) AU715512B2 (cg-RX-API-DMAC7.html)
CA (1) CA2250478A1 (cg-RX-API-DMAC7.html)
DE (1) DE69722952T2 (cg-RX-API-DMAC7.html)
DK (1) DK0936902T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201283T3 (cg-RX-API-DMAC7.html)
GB (1) GB9607035D0 (cg-RX-API-DMAC7.html)
NO (1) NO984462L (cg-RX-API-DMAC7.html)
PT (1) PT936902E (cg-RX-API-DMAC7.html)
WO (1) WO1997036578A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA972837B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JP2000500744A (ja) 1995-11-09 2000-01-25 マイクロバイオロジカル リサーチ オーソリティー ワクチン接種および遺伝子治療のためのマイクロカプセル化ｄｎａ
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
JP2007537288A (ja) 2004-05-12 2007-12-20 バクスター インターナショナル インコーポレイテッド オリゴヌクレオチド含有マイクロスフェア、１型糖尿病を処置する医薬の製造のための、その使用
PT1765294E (pt) 2004-05-12 2008-12-30 Baxter Healthcare Sa Microesferas de ácido nucleico, sua produção e entrega
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
EP2647712A3 (en) 2006-08-04 2013-11-20 Baxter International Inc Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
EP2146691A2 (en) 2007-04-17 2010-01-27 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
CN120514877A (zh) * 2018-07-23 2025-08-22 川斯勒佰尔公司 信使rna的干粉制剂
AU2020206984A1 (en) * 2019-01-09 2021-07-15 Ziccum Ab Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5626871A (en) * 1992-06-12 1997-05-06 Teijin Limited Preparation for intratracheobronchial administration
DE69332240T2 (de) * 1992-06-12 2003-04-10 Teijin Ltd., Osaka Ultrafeines pulver zur inhalation und dessen herstellung
JPH08511418A (ja) * 1993-04-19 1996-12-03 メディソーブ・テクノロジーズ・インターナショナル・リミテッド・パートナーシップ 生分解性極微粒子からのアンチセンスオリゴデオキシリボヌクレオチドの徐放運搬による長期作用のある処置
CA2190502A1 (en) * 1994-05-18 1995-11-23 Robert M. Platz Methods and compositions for the dry powder formulation of interferons
KR970705979A (ko) * 1994-09-29 1997-11-03 디 히스 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles)
AU5417796A (en) * 1995-03-07 1996-09-23 University Of Pittsburgh A dry powder formulation for gene therapy
AU714584B2 (en) * 1995-07-21 2000-01-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles

Also Published As

Publication number Publication date
AU715512B2 (en) 2000-02-03
AR007493A1 (es) 1999-11-10
GB9607035D0 (en) 1996-06-05
DE69722952T2 (de) 2003-12-11
ZA972837B (en) 1998-04-03
EP0936902A1 (en) 1999-08-25
NO984462D0 (no) 1998-09-25
DE69722952D1 (de) 2003-07-24
ES2201283T3 (es) 2004-03-16
PT936902E (pt) 2003-11-28
WO1997036578A1 (en) 1997-10-09
CA2250478A1 (en) 1997-10-09
EP0936902B1 (en) 2003-06-18
DK0936902T3 (da) 2003-10-06
JP2000507568A (ja) 2000-06-20
AU2302097A (en) 1997-10-22
ATE243027T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
NO984462D0 (no) Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi
DK1212327T3 (da) Pyrazolopyrimidiner som terapeutiske midler
PL319600A1 (en) Spray-dried microparticles as therapeutic carriers
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
EE04528B1 (et) Teraapias kasutatavad spirofuropridiinide aralklamiinid
IT1295047B1 (it) Preparati farmaceutici per somministrazione intranasale
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20022692L (no) Terapeutiske midler
DE60008752D1 (de) Selbstkühlende dose
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
ES1044983Y (es) Aparato de termoestimulacion para tratamientos terapeuticos.
NO20021976L (no) Selektiv leverterapi
NO20016301D0 (no) Terapeutiske midler
NO20023003L (no) Benzofenon-glykopyranosider, samt fremstilling og terapeutisk anvendelse
GB9911238D0 (en) Therapeutic use
ATE261096T1 (de) Selbstkühlende dose
IT235934Y1 (it) Perfezionamenti agli apparecchi stimolatori, in particolare per usoterapeutico
NO20003606L (no) Triazepinoner, fremgangsmÕte for deres fremstilling, samt deres terapeutiske anvendelse
GB9902139D0 (en) Therapeutic non-autologous proteins
GB9926058D0 (en) Therapeutic proteins
SE9702595D0 (sv) new therapeutic use
BR7702971U (pt) Disposição introduzida em rodízio para cortina
BR7600951U (pt) Almofada terapéutica
GB9912184D0 (en) Therapeutic use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application